Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Jun 13, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a program called the Home Hazard Removal Program (HARP), which is designed to help people with physical disabilities reduce the risk of falling by identifying and fixing dangers in their homes. The study will look at how well an adapted version of HARP works for adults aged 45 to 64 who have had a physical disability for at least five years and who live in the City of St. Louis. To take part, individuals should have some difficulty with daily activities and either have fallen recently, feel unsteady when walking or standing, or worry about falling.
Participants in the study will be randomly placed into two groups: one will receive the adapted HARP program right away, and the other will wait to receive it later. The study will track falls, injuries, changes made to the home to reduce hazards, and participants’ fear of falling over a year. This is a small, early-stage study to see if the program is practical, affordable, and helpful for people with disabilities. The researchers will also use special methods to make sure the program can be shared and used widely in the future. People who live in institutions like nursing homes are not eligible to join this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 45-64 years
- • self-report of difficulty with ≥2 daily activities
- • have had a physical disability for ≥5 years (e.g., spinal cord injury, cerebral palsy, post-polio syndrome, stroke, amputation)
- • live in the City of St. Louis
- • had a fall in the past year, or are worried about falling, or feel unsteady when standing or walking
- Exclusion Criteria:
- • • individuals who are institutionalized
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Susan L Stark, PhD
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported